Nathalie Labarriere

Nathalie Labarriere

UNVERIFIED PROFILE

Are you Nathalie Labarriere?   Register this Author

Register author
Nathalie Labarriere

Nathalie Labarriere

Publications by authors named "Nathalie Labarriere"

Are you Nathalie Labarriere?   Register this Author

45Publications

874Reads

9Profile Views

MicroRNAs in Tumor Exosomes Drive Immune Escape in Melanoma.

Cancer Immunol Res 2020 Feb 19;8(2):255-267. Epub 2019 Dec 19.

CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-19-0522DOI Listing
February 2020

Viral and tumor antigen-specific CD8 T-cell responses in Merkel cell carcinoma.

Cell Immunol 2019 Oct 1;344:103961. Epub 2019 Aug 1.

CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France; LabEx IGO "Immunotherapy, Graft, Oncology", Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellimm.2019.103961DOI Listing
October 2019

Merkel cell carcinoma and cellular cytotoxicity: sensitivity to cellular lysis and screening for potential target antigens suitable for antibody-dependent cellular cytotoxicity.

Cancer Immunol Immunother 2018 Aug 28;67(8):1209-1219. Epub 2018 May 28.

Centre de Recherche en Cancérologie et Immunologie Nantes-Angers (CRCINA), Institut National de la Santé et de la Recherche Médicale (INSERM U1232), Centre national de la recherche scientifique (CNRS), Université d'Angers, Université de Nantes, 8 Quai Moncousu, 44007, Nantes Cedex, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00262-018-2176-2
Publisher Site
http://dx.doi.org/10.1007/s00262-018-2176-2DOI Listing
August 2018

Emergence of High-Avidity Melan-A-Specific Clonotypes as a Reflection of Anti-PD-1 Clinical Efficacy.

Cancer Res 2017 12 6;77(24):7083-7093. Epub 2017 Dec 6.

CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-17-1856DOI Listing
December 2017

PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?

Oncoimmunology 2017 14;7(1):e1364828. Epub 2017 Sep 14.

CRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2017.1364828DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739549PMC
September 2017

Immunotherapies in transplantation and cancer: 22nd NAT meeting/2nd NAT LabEx IGO joint meeting; 1-2 June 2017, Nantes, France.

Immunotherapy 2017 09;9(11):867-870

CRCINA, Inserm UMR1232, 8 Quai Moncousu, 44007 Nantes Cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2017-0094DOI Listing
September 2017

A lineage-specific methylation pattern controls the transcription of the polycistronic mRNA coding MELOE melanoma antigens.

Melanoma Res 2015 Aug;25(4):279-83

aInserm, UMR 892 bFaculty of Science, University of Nantes cCNRS, UMR 6299, Nantes dInserm, UMR1169, Le Kremlin-Bicetre, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CMR.0000000000000167DOI Listing
August 2015

The melanoma antigens MELOE-1 and MELOE-2 are translated from a bona fide polycistronic mRNA containing functional IRES sequences.

PLoS One 2013 25;8(9):e75233. Epub 2013 Sep 25.

Institut National de la Santé et de la Recherche Médicale, U892, Nantes, France ; University of Nantes, Nantes, France ; Centre national de la recherche scientifique, UMR 6299, Nantes, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0075233PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783476PMC
July 2014

Overexpression of meloe gene in melanomas is controlled both by specific transcription factors and hypomethylation.

PLoS One 2013 25;8(9):e75421. Epub 2013 Sep 25.

Institut National de la Santé et de la Recherche Médicale, UMR 892, Nantes, France ; University of Nantes, Nantes, France ; Centre national de la recherche scientifique, UMR 6299, Nantes, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0075421PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783405PMC
July 2014

Soluble HLA-I/peptide monomers mediate antigen-specific CD8 T cell activation through passive peptide exchange with cell-bound HLA-I molecules.

J Immunol 2014 Jun 21;192(11):5090-7. Epub 2014 Apr 21.

INSERM, U892, Nantes F-44007, France; Centre National de la Recherche Scientifique, U6299, Nantes F-44007, France; Université de Nantes, Nantes F-44007 France; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1303226DOI Listing
June 2014

[Melanoma: Cellular and vaccinal immunotherapy].

Bull Acad Natl Med 2014 Feb;198(2):309-19; discussion 319

View Article

Download full-text PDF

Source
February 2014

Is antigen specificity the key to efficient adoptive T-cell therapy?

Immunotherapy 2011 Apr;3(4):495-505

Unite Mixte de Recherche Institut National de la Sante et de la Recherche Medicale, Unite 892, Centre de Recherche en Canerologie Nantes-Angers, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt.11.16DOI Listing
April 2011

A long peptide from MELOE-1 contains multiple HLA class II T cell epitopes in addition to the HLA-A*0201 epitope: an attractive candidate for melanoma vaccination.

Cancer Immunol Immunother 2011 Mar 16;60(3):327-37. Epub 2010 Nov 16.

INSERM U892-CRCNA, IRTUN, 8 Quai Moncousu, BP70721, 44007 Nantes cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-010-0938-6DOI Listing
March 2011

A new tyrosinase epitope recognized in the HLA-B*4002 context by CTL from melanoma patients.

Cancer Immunol Immunother 2009 Feb 9;58(2):271-80. Epub 2008 Jul 9.

INSERM U892, 9 quai Moncousu, 44093, Nantes cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-008-0551-0DOI Listing
February 2009

MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency.

J Exp Med 2008 Oct 20;205(11):2673-82. Epub 2008 Oct 20.

Institut National de Santé et de Recherche Médicale, Unité Mixte de Recherche 892, 44093 Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20081356DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2571940PMC
October 2008

[Passive immunotherapy of melanoma].

Bull Cancer 2003 Jul;90(7):583-6

Inserm U463, Institut de Biologie, CHR, 9, quai Moncousu, 44093 Nantes, France.

View Article

Download full-text PDF

Source
July 2003

Therapeutic efficacy of melanoma-reactive TIL injected in stage III melanoma patients.

Cancer Immunol Immunother 2002 Nov 18;51(10):532-8. Epub 2002 Sep 18.

Unité INSERM U463, 9 Quai Moncousu, 44093 Nantes Cedex 1, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-002-0313-3DOI Listing
November 2002

A ras-mutated peptide targeted by CTL infiltrating a human melanoma lesion.

J Immunol 2002 May;168(9):4802-8

Institut de Biologie, Institut National de la Santé et de la Recherche Médicale, Unité 463, and Faculté des Sciences et Techniques de Nantes, Nantes, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.168.9.4802DOI Listing
May 2002